Vaughan TL - Search Results

1

Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ. Rudolph RE, et al. Among authors: vaughan tl. Ann Intern Med. 2000 Apr 18;132(8):612-20. doi: 10.7326/0003-4819-132-8-200004180-00003. Ann Intern Med. 2000. PMID: 10766679

2

Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.

Vaughan TL, Davis S, Kristal A, Thomas DB. Vaughan TL, et al. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):85-92. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7742727

3

Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States).

Farrow DC, Vaughan TL. Farrow DC, et al. Among authors: vaughan tl. Cancer Causes Control. 1996 May;7(3):322-7. doi: 10.1007/BF00052937. Cancer Causes Control. 1996. PMID: 8734825

4

Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus.

Moe GL, Kristal AR, Levine DS, Vaughan TL, Reid BJ. Moe GL, et al. Among authors: vaughan tl. Nutr Cancer. 2000;36(1):7-13. doi: 10.1207/S15327914NC3601_2. Nutr Cancer. 2000. PMID: 10798210

5

Family history of cancer and risk of esophageal and gastric cancers in the United States.

Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr. Dhillon PK, et al. Among authors: vaughan tl. Int J Cancer. 2001 Jul 1;93(1):148-52. doi: 10.1002/ijc.1294. Int J Cancer. 2001. PMID: 11391635

6

Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.

Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, Sanchez CA, Paulson TG, Rabinovitch PS, Reid BJ, Spitz MR, Vaughan TL. Chao DL, et al. Among authors: vaughan tl. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1935-40. doi: 10.1158/1055-9965.EPI-06-0492. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035402

7

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, Odze RD, Ayub K, Rabinovitch PS, Vaughan TL, Reid BJ. Galipeau PC, et al. Among authors: vaughan tl. PLoS Med. 2007 Feb;4(2):e67. doi: 10.1371/journal.pmed.0040067. PLoS Med. 2007. PMID: 17326708 Free PMC article.

8

Gastric fluid bile concentrations and risk of Barrett's esophagus.

Nason KS, Farrow DC, Haigh G, Lee SP, Bronner MP, Rosen SN, Vaughan TL. Nason KS, et al. Among authors: vaughan tl. Interact Cardiovasc Thorac Surg. 2007 Jun;6(3):304-7. doi: 10.1510/icvts.2006.143370. Epub 2007 Feb 8. Interact Cardiovasc Thorac Surg. 2007. PMID: 17669852

9

Central adiposity and risk of Barrett's esophagus.

Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Edelstein ZR, et al. Among authors: vaughan tl. Gastroenterology. 2007 Aug;133(2):403-11. doi: 10.1053/j.gastro.2007.05.026. Epub 2007 May 21. Gastroenterology. 2007. PMID: 17681161

10

Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.

Siahpush SH, Vaughan TL, Lampe JN, Freeman R, Lewis S, Odze RD, Blount PL, Ayub K, Rabinovitch PS, Reid BJ, Chen C. Siahpush SH, et al. Among authors: vaughan tl. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2387-95. doi: 10.1158/1055-9965.EPI-06-0986. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18006928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters